Ms. Holmes was convicted in January of four counts of defrauding investors in a yearslong scheme at the company that claimed to be able to do comprehensive tests with a tiny amount of blood. She faces up to 20 years in prison on each count at her Nov. 18 sentencing.
She requested a new trial in September, saying a witness had recanted his testimony. But that witness denied those claims.
U.S. District Judge Edward Davila ruled Nov. 7 that Ms. Holmes didn’t produce material new evidence or prove government misconduct and that a new trial was unlikely to lead to an acquittal, the Journal reported.
Her attorneys didn’t respond to a request from the news outlet for comment. The news was first reported Nov. 7 by Reuters.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
